MilliporeSigma has awarded MIT spin-out Combined Therapeutics a check for $250,000 as the winner of its 2020 Advance Biotech Grant.
Combined Therapeutics (CTx) is an early stage startup developing the second generation of therapeutic and intelligent messenger RNA (mRNA). The pre-clinical biotech aims to develop therapies to treat and prevent liver cancer using its mRNA delivery and modulation platform.
The firm—founded by MIT professors Robert Langer and Dan Anderson, along with entrepreneur Romain Micol—was the prestigious winner Thursday of the MilliporeSigma Advance Biotech Grant, part of the 2020 National Xconomy Awards event.
The Advance Biotech Grant, sponsored and presented by MilliporeSigma,... Read more »
UNDERWRITERS AND PARTNERS
Author: Dan Stanton
Date : 2020-09-25T12:59:35.000Z